New determinants of prognosis in bacterial infections in cirrhosis.

Publisher: Baishideng Publishing Group Country of Publication: United States NLM ID: 100883448 Publication Model: Print Cited Medium: Internet ISSN: 2219-2840 (Electronic) Linking ISSN: 10079327 NLM ISO Abbreviation: World J Gastroenterol Subsets: MEDLINE

Publication: 2014- : Pleasanton, CA : Baishideng Publishing Group
Original Publication: Beijing : WJG Press, c1998-

Anti-Bacterial Agents/*therapeutic use ; Bacterial Infections/*therapy ; Liver Cirrhosis/*complications; Adrenal Glands/metabolism ; Adrenal Glands/physiopathology ; Animals ; Bacterial Infections/diagnosis ; Bacterial Infections/metabolism ; Bacterial Infections/microbiology ; Bacterial Infections/physiopathology ; Drug Resistance, Multiple, Bacterial ; Endothelium, Vascular/metabolism ; Endothelium, Vascular/physiopathology ; Hospitalization ; Humans ; Liver Cirrhosis/metabolism ; Liver Cirrhosis/physiopathology ; Risk Factors ; Treatment Outcome

Despite major advances in the knowledge and management of liver diseases achieved in recent decades, decompensation of cirrhosis still carries a high burden of morbidity and mortality. Bacterial infections are one of the main causes of decompensation. It is very important for clinical management to be aware of the population with the highest risk of poor outcome. This review deals with the new determinants of prognosis in patients with cirrhosis and bacterial infections reported recently. Emergence of multiresistant bacteria has led to an increasing failure rate of the standard empirical antibiotic therapy recommended by international guidelines. Moreover, it has been recently reported that endothelial dysfunction is associated with the degree of liver dysfunction and, in infected patients, with the degree of sepsis. It has also been reported that relative adrenal insufficiency is frequent in the non-critically ill cirrhotic population and it is associated with a higher risk of developing infection, severe sepsis, hepatorenal syndrome and death. We advise a change in the standard empirical antibiotic therapy in patients with high risk for multiresistant infections and also to take into account endothelial and adrenal dysfunction in prognostic models in hospitalized patients with decompensated cirrhosis.

N Engl J Med. 2004 Apr 15;350(16):1629-38. (PMID: 15084695)
Infection. 2009 Feb;37(1):2-8. (PMID: 19169633)
Endocrinol Metab Clin North Am. 2006 Dec;35(4):823-38, x. (PMID: 17127149)
J Hepatol. 1991 Jan;12(1):118-23. (PMID: 2007768)
Chest. 2003 Sep;124(3):1016-20. (PMID: 12970032)
Clin Infect Dis. 1998 May;26(5):1066-70. (PMID: 9597225)
Hepatology. 1998 May;27(5):1227-32. (PMID: 9581675)
Hepatology. 2009 Jun;49(6):2087-107. (PMID: 19475696)
J Hepatol. 2000 Jan;32(1):142-53. (PMID: 10673079)
Gastroenterology. 1980 Oct;79(4):707-15. (PMID: 7409388)
World J Gastroenterol. 2013 Jan 28;19(4):445-56. (PMID: 23382623)
Hepatology. 2006 Apr;43(4):673-81. (PMID: 16557538)
N Engl J Med. 1999 Aug 5;341(6):403-9. (PMID: 10432325)
Hepatology. 2002 Jan;35(1):140-8. (PMID: 11786970)
N Engl J Med. 2003 Feb 20;348(8):727-34. (PMID: 12594318)
Hepatology. 2006 Nov;44(5):1288-95. (PMID: 17058239)
Hepatology. 2003 Aug;38(2):452-9. (PMID: 12883490)
Clin Gastroenterol Hepatol. 2012 Nov;10(11):1291-8. (PMID: 22902776)
Lancet. 1991 Mar 30;337(8744):776-8. (PMID: 1706450)
Eur Addict Res. 2010;16(4):193-201. (PMID: 20606444)
J Gastroenterol Hepatol. 2003 Aug;18(8):927-33. (PMID: 12859722)
Hepatology. 1993 Nov;18(5):1139-43. (PMID: 8225220)
Liver Int. 2013 Jan;33(1):31-9. (PMID: 23121656)
N Engl J Med. 2009 Sep 24;361(13):1279-90. (PMID: 19776409)
Hepatology. 2005 Aug;42(2):439-47. (PMID: 15977202)
Crit Care Med. 2005 Jun;33(6):1254-9. (PMID: 15942340)
Clin Microbiol Infect. 2012 Mar;18(3):268-81. (PMID: 21793988)
J Hepatol. 2010 Sep;53(3):397-417. (PMID: 20633946)
Hepatogastroenterology. 2003 Sep-Oct;50(53):1482-6. (PMID: 14571769)
Am J Clin Pathol. 1997 Dec;108(6):652-7. (PMID: 9384446)
Hepatology. 1988 Sep-Oct;8(5):1151-7. (PMID: 2971015)
Gastroenterology. 1992 Jul;103(1):264-74. (PMID: 1612333)
J Korean Med Sci. 2006 Aug;21(4):666-71. (PMID: 16891810)
Scand J Infect Dis. 2009;41(11-12):847-51. (PMID: 19922067)
Scand J Gastroenterol. 2012 Feb;47(2):212-6. (PMID: 22191479)
Clin Gastroenterol Hepatol. 2010 Nov;8(11):979-85. (PMID: 20621200)
World J Gastroenterol. 2008 May 7;14(17):2757-62. (PMID: 18461661)
Gastroenterology. 1985 Feb;88(2):430-5. (PMID: 3965332)
Hepatology. 2012 May;55(5):1551-61. (PMID: 22183941)
Best Pract Res Clin Endocrinol Metab. 2009 Feb;23(1):65-77. (PMID: 19285261)
CMAJ. 2010 Dec 14;182(18):1971-7. (PMID: 21059778)
J Hepatol. 2012;56 Suppl 1:S1-12. (PMID: 22300459)
Clin Infect Dis. 2009 May 1;48(9):1230-6. (PMID: 19302016)
Korean J Intern Med. 2004 Sep;19(3):160-4. (PMID: 15481607)
Gut. 2011 Aug;60(8):1133-8. (PMID: 21427197)
Hepatol Int. 2013 Mar;7(1):72-9. (PMID: 26201623)
BMC Infect Dis. 2009 Apr 12;9:41. (PMID: 19361340)
Clin Gastroenterol Hepatol. 2011 Jul;9(7):595-601. (PMID: 21545846)
Postgrad Med J. 2008 Dec;84(998):662-70. (PMID: 19201943)
Hepatology. 2005 Mar;41(3):422-33. (PMID: 15723320)
Hepatology. 1995 Jan;21(1):35-40. (PMID: 7528711)
J Hepatol. 2012 Apr;56(4):825-32. (PMID: 22173153)
Eur J Gastroenterol Hepatol. 2012 Oct;24(10):1234-7. (PMID: 22713510)
Gastroenterology. 2010 Oct;139(4):1246-56, 1256.e1-5. (PMID: 20558165)
Hepatology. 1994 Dec;20(6):1495-501. (PMID: 7982650)
Hepatology. 2008 Dec;48(6):1924-31. (PMID: 19003911)
Hepatology. 1994 Nov;20(5):1343-50. (PMID: 7927270)
J Hepatol. 2013 Mar;58(3):593-608. (PMID: 23419824)
Hepatology. 2012 Oct;56(4):1439-47. (PMID: 22532296)
Hepatology. 2013 Nov;58(5):1757-65. (PMID: 23728792)

Keywords: Bacterial; Bacterial infections; Drug resistance; Endothelial dysfunction; Liver cirrhosis; Relative adrenal insufficiency

0 (Anti-Bacterial Agents)

Date Created: 20140627 Date Completed: 20150413 Latest Revision: 20220409

20231215

PMC4064071

10.3748/wjg.v20.i23.7252

24966596